Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 31, Supplement A, 1993   [Index by Author] 


Down Other Departments
Down Articles


[Search ALL Issues]

Front Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Other Departments Back

Roger G. Finch and David Greenwood
Preface
J. Antimicrob. Chemother. 1993 31: iii; doi:10.1093/jac/31.suppl_A.iii [PDF] [Request Permissions]  

Articles Back

Robert C. Moellering, Jr
Meeting the challenges of β-lactamases
J. Antimicrob. Chemother. 1993 31: 1-8; doi:10.1093/jac/31.suppl_A.1 [Abstract] [PDF] [Request Permissions]  

D. M. Livermore
Determinants of the activity of β-lactamase inhibitor combinations
J. Antimicrob. Chemother. 1993 31: 9-21; doi:10.1093/jac/31.suppl_A.9 [Abstract] [PDF] [Request Permissions]  

J. F. Acar, F. W. Goldstein, and M. D. Kitzis
Susceptibility survey of piperacillin alone and in the presence of tazobactam
J. Antimicrob. Chemother. 1993 31: 23-28; doi:10.1093/jac/31.suppl_A.23 [Abstract] [PDF] [Request Permissions]  

P. C. Appelbaum
Comparative susceptibility profile of piperacillin/tazobactam against anaerobic bacteria
J. Antimicrob. Chemother. 1993 31: 29-38; doi:10.1093/jac/31.suppl_A.29 [Abstract] [PDF] [Request Permissions]  

F. Sörgel and M. Kinzig
The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam
J. Antimicrob. Chemother. 1993 31: 39-60; doi:10.1093/jac/31.suppl_A.39 [Abstract] [PDF] [Request Permissions]  

C.E. Nord, B. Brismar, B. Kasholm-Tengve, and G. Tunevall
Effect of piperacillin/tazobactam treatment on human bowel microflora
J. Antimicrob. Chemother. 1993 31: 61-65; doi:10.1093/jac/31.suppl_A.61 [Abstract] [PDF] [Request Permissions]  

Sherwood L. Gorbach
Treatment of intra-abdominal infections
J. Antimicrob. Chemother. 1993 31: 67-78; doi:10.1093/jac/31.suppl_A.67 [Abstract] [PDF] [Request Permissions]  

A.-E. Eklund, C. E. Nord, and Swedish Study Group
A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections
J. Antimicrob. Chemother. 1993 31: 79-85; doi:10.1093/jac/31.suppl_A.79 [Abstract] [PDF] [Request Permissions]  

Y. Mouton, O. Leroy, C. Beuscart, C. Chidiac, E. Senneville, F. Ajana, P. Lecocq, and Study Group
Efficacy, safety and tolerance of parenteral piperacillin/tazobactam in the treatment of patients with lower respiratory tract infections
J. Antimicrob. Chemother. 1993 31: 87-95; doi:10.1093/jac/31.suppl_A.87 [Abstract] [PDF] [Request Permissions]  

R. Wise
The efficacy and safety of piperacillin/tazobactam in the therapy of bacteraemia
J. Antimicrob. Chemother. 1993 31: 97-104; doi:10.1093/jac/31.suppl_A.97 [Abstract] [PDF] [Request Permissions]  

Helmut Tassler, Wolfgang Cullmann, and Dieter Elhardt
Therapy of soft tissue infections with piperacillin/tazobactam
J. Antimicrob. Chemother. 1993 31: 105-112; doi:10.1093/jac/31.suppl_A.105 [Abstract] [PDF] [Request Permissions]  

Olatunde Kuye, Jennifer Teal, Vern G. De Vries, Carol A. Morrow, and Francis P. Tally
Safety profile of piperacillin/tazobactam in phase I and III clinical studies
J. Antimicrob. Chemother. 1993 31: 113-124; doi:10.1093/jac/31.suppl_A.113 [Abstract] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.